2014
Management of Fever in Ambulatory HIV-Infected Adults in Resource-Limited Settings
Brentlinger PE, Silva WP, Buene M, Morais L, Valverde E, Vermund SH, Moon TD. Management of Fever in Ambulatory HIV-Infected Adults in Resource-Limited Settings. JAIDS Journal Of Acquired Immune Deficiency Syndromes 2014, 67: 304-309. PMID: 25314251, PMCID: PMC5844466, DOI: 10.1097/qai.0000000000000304.Peer-Reviewed Original ResearchMeSH KeywordsAdultAIDS-Related Opportunistic InfectionsAmbulatory CareAnti-Bacterial AgentsAnti-HIV AgentsAntiretroviral Therapy, Highly ActiveBacterial InfectionsCD4 Lymphocyte CountDisease ManagementFemaleFeverHIV InfectionsHumansMaleMultivariate AnalysisOutcome Assessment, Health CarePractice Guidelines as TopicProspective StudiesRisk FactorsViral LoadConceptsManagement of feverLow CD4 T-lymphocyte countCD4 T-lymphocyte countLower body mass indexBacterial blood stream infectionsSpecific alternative diagnosesT-lymphocyte countsHistory of feverProspective observational studyBlood stream infectionsBody mass indexResource limited settingsAmbulatory HIVAntiretroviral therapyMalaria testingLower hemoglobinMass indexAdverse outcomesAlternative diagnosesObservational studyAxillary temperatureGuideline performanceMultivariate analysisHIVFever
2013
Bacteremia as a Cause of Fever in Ambulatory, HIV-Infected Mozambican Adults: Results and Policy Implications from a Prospective Observational Study
Moon TD, Silva WP, Buene M, Morais L, Valverde E, Vermund SH, Brentlinger PE. Bacteremia as a Cause of Fever in Ambulatory, HIV-Infected Mozambican Adults: Results and Policy Implications from a Prospective Observational Study. PLOS ONE 2013, 8: e83591. PMID: 24386229, PMCID: PMC3875454, DOI: 10.1371/journal.pone.0083591.Peer-Reviewed Original ResearchConceptsProspective observational studyAmbulatory HIVFebrile patientsObservational studySusceptibility patternsLarge prospective observational studyT-lymphocyte countsSpecific antimicrobial therapyCause of feverCases of bacteremiaFirst-line antibioticsPeripheral health unitsAntimicrobial susceptibility patternsNon-physician cliniciansNon-typhoid SalmonellaResource-limited settingsBlood culture specimensLow CD4Presumptive antibioticsClinical characteristicsRecent feverClinical profileLower hemoglobinPrescribing practicesAntimicrobial therapy
2012
HPV Genotype Distribution in Cervical Intraepithelial Neoplasia among HIV-Infected Women in Pune, India
Mane A, Nirmalkar A, Risbud AR, Vermund SH, Mehendale SM, Sahasrabuddhe VV. HPV Genotype Distribution in Cervical Intraepithelial Neoplasia among HIV-Infected Women in Pune, India. PLOS ONE 2012, 7: e38731. PMID: 22723879, PMCID: PMC3378535, DOI: 10.1371/journal.pone.0038731.Peer-Reviewed Original ResearchConceptsCarcinogenic HPV genotypesHPV genotypesLow CD4HPV infectionCIN3 lesionsCommon HPV genotypesHPV genotype distributionMultiple HPV genotypesCombination antiretroviral therapyCervical intraepithelial neoplasiaCarcinogenic HPV infectionHalf of womenQuarter of womenHPV type detectionLifetime sexual partnersCarcinogenic HPVHPV16 detectionAntiretroviral therapyHPV genotypingComposite endpointOrder of prevalenceIntraepithelial neoplasiaCervical cancerHPV 16Observational study
2011
Nurturing the Global Workforce in Clinical Research: The National Institutes of Health Fogarty International Clinical Scholars and Fellows Program
Heimburger DC, Carothers CL, Gardner P, Primack A, Warner TL, Vermund SH. Nurturing the Global Workforce in Clinical Research: The National Institutes of Health Fogarty International Clinical Scholars and Fellows Program. American Journal Of Tropical Medicine And Hygiene 2011, 85: 971-978. PMID: 22144429, PMCID: PMC3225173, DOI: 10.4269/ajtmh.2011.11-0141.Peer-Reviewed Original ResearchConceptsHealth research partnershipsChronic disease researchClinical research settingClinical trialsObservational studyGlobal health expertsClinical investigatorsInfectious diseasesClinical researchTranslational researchHealth expertsInternational investigatorsNational InstituteFogarty International Clinical Research ScholarsHealth researchClinical scholarsDisease researchGlobal health researchResearch settingsHigh-impact journalsInvestigatorsTraining opportunitiesDiseaseTrials
2001
No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress
Murphy D, Durako S, Moscicki A, Vermund S, Ma Y, Schwarz D, Muenz L, network T. No change in health risk behaviors over time among HIV infected adolescents in care: role of psychological distress. Journal Of Adolescent Health 2001, 29: 57-63. PMID: 11530304, DOI: 10.1016/s1054-139x(01)00287-7.Peer-Reviewed Original ResearchConceptsHealth risk behaviorsRecent sexual activityRisk behaviorsUnprotected sexPsychological distressLast intercourseHigh-risk sexual behaviorSexual activityHealth-related anxietySexual behaviorSexual risk behaviorsFrequent alcohol useMarijuana useUse of alcoholComputer-assisted self-administered interviewPrimary careStudy visitObservational studyHIVClinical sitesHealth interventionsDepressed adolescentsAlcohol useHealth anxietyMeasures analysis
1991
Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS
STUDY T, Graham N, Zeger S, Park L, Saah A, Phair J, Detels R, Vermund S, Ho M. Effect of zidovudine and Pneumocystis carinii pneumonia prophylaxis on progression of HIV-1 infection to AIDS. The Lancet 1991, 338: 265-269. PMID: 1677108, DOI: 10.1016/0140-6736(91)90414-k.Peer-Reviewed Original ResearchMeSH KeywordsAcquired Immunodeficiency SyndromeAerosolsCD4-Positive T-LymphocytesEvaluation Studies as TopicFollow-Up StudiesHIV SeropositivityHIV-1HumansLeukocyte CountMalePentamidinePneumonia, PneumocystisProspective StudiesRegression AnalysisRisk FactorsTime FactorsTrimethoprim, Sulfamethoxazole Drug CombinationZidovudineConceptsPneumocystis carinii pneumoniaEffect of zidovudineHIV-1 infectionPCP prophylaxisProbability of progressionLymphocytes/First episodePneumocystis carinii pneumonia prophylaxisHIV-1-infected individualsHIV-1-seropositive menMonth intervalsPrimary PCP prophylaxisEfficacy of zidovudinePresence of HIVRate of progressionMultivariate log-linear modelPneumonia prophylaxisMore CD4Primary prophylaxisZidovudine therapyLymphocyte countCarinii pneumoniaClinical trialsObservational studyProphylaxis